[1] |
STICOVA E, JIRSA M. ABCB4 disease: Many faces of one gene deficiency[J]. Ann Hepatol, 2020, 19( 2): 126- 133. DOI: 10.1016/j.aohep.2019.09.010.
|
[2] |
AVENA A, PUGGELLI S, MORRIS M, et al. ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed[J]. Dig Liver Dis, 2021, 53( 3): 329- 344. DOI: 10.1016/j.dld.2020.12.003.
|
[3] |
STICOVA E, JIRSA M, PAWŁOWSKA J. New insights in genetic cholestasis: From molecular mechanisms to clinical implications[J]. Can J Gastroenterol Hepatol, 2018, 2018: 2313675. DOI: 10.1155/2018/2313675.
|
[4] |
STÄTTERMAYER AF, HALILBASIC E, WRBA F, et al. Variants in ABCB4(MDR3) across the spectrum of cholestatic liver diseases in adults[J]. J Hepatol, 2020, 73( 3): 651- 663. DOI: 10.1016/j.jhep.2020.04.036.
|
[5] |
FALCÃO D, PEDROTO I, MOREIRA T. The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: A case series[J]. Dig Liver Dis, 2022, 54( 2): 221- 227. DOI: 10.1016/j.dld.2021.07.003.
|
[6] |
NAYAGAM JS, WILLIAMSON C, JOSHI D, et al. Review article: Liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1[J]. Aliment Pharmacol Ther, 2020, 52( 11-12): 1628- 1639. DOI: 10.1111/apt.16118.
|
[7] |
WANG HH, PORTINCASA P, LIU M, et al. Genetic analysis of ABCB4 mutations and variants related to the pathogenesis and pathophysiology of low phospholipid-associated cholelithiasis[J]. Genes, 2022, 13( 6): 1047. DOI: 10.3390/genes13061047.
|
[8] |
van NIEKERK J, KERSTEN R, BEUERS U. Role of bile acids and the biliary HCO(3)(-) umbrella in the pathogenesis of primary biliary cholangitis[J]. Clin Liver Dis, 2018, 22( 3): 457- 479. DOI: 10.1016/j.cld.2018.03.013.
|
[9] |
REICHERT MC, HALL RA, KRAWCZYK M, et al. Genetic determinants of cholangiopathies: Molecular and systems genetics[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864( 4 Pt B): 1484- 1490. DOI: 10.1016/j.bbadis.2017.07.029.
|
[10] |
BAI J, LI L, LIU H, et al. A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: A case report[J]. Ann Transl Med, 2021, 9( 5): 426. DOI: 10.21037/atm-20-3747.
|
[11] |
AMIRNENI S, HAEP N, MA GAD, et al. Molecular overview of progressive familial intrahepatic cholestasis[J]. World J Gastroenterol, 2020, 26( 47): 7470- 7484. DOI: 10.3748/wjg.v26.i47.7470.
|
[12] |
DONG C, CONDAT B, PICON-COSTE M, et al. Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities[J]. JHEP Rep, 2021, 3( 2): 100201. DOI: 10.1016/j.jhepr.2020.100201.
|
[13] |
REICHERT MC, LAMMERT F. ABCB4 gene aberrations in human liver disease: An evolving spectrum[J]. Semin Liver Dis, 2018, 38( 4): 299- 307. DOI: 10.1055/s-0038-1667299.
|
[14] |
XIAO JP, LI ZY, SONG YT, et al. Molecular pathogenesis of intrahepatic cholestasis of pregnancy[J]. Can J Gastroenterol Hepatol, 2021, 2021: 6679322. DOI: 10.1155/2021/6679322.
|
[15] |
JACQUEMIN E, de VREE JM, CRESTEIL D, et al. The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood[J]. Gastroenterology, 2001, 120( 6): 1448- 1458. DOI: 10.1053/gast.2001.23984.
|
[16] |
LUCENA JF, HERRERO JI, QUIROGA J, et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis[J]. Gastroenterology, 2003, 124( 4): 1037- 1042. DOI: 10.1053/gast.2003.50144.
|
[17] |
VITALE G, GITTO S, RAIMONDI F, et al. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing[J]. J Gastroenterol, 2018, 53( 8): 945- 958. DOI: 10.1007/s00535-017-1423-1.
|
[18] |
TERZIROLI BERETTA-PICCOLI B, THOMPSON R, FOSKETT P, et al. A heterozygous ABCB4, RUNDC3B, and ABCB1 deletion associated with severe cholestatic liver disease in adulthood[J]. Hepatology, 2019, 70( 4): 1484- 1487. DOI: 10.1002/hep.30783.
|
[19] |
MHATRE S, WANG ZM, NAGRANI R, et al. Common genetic variation and risk of gallbladder cancer in India: A case-control genome-wide association study[J]. Lancet Oncol, 2017, 18( 4): 535- 544. DOI: 10.1016/S1470-2045(17)30167-5.
|
[20] |
KATZENELLENBOGEN M, MIZRAHI L, PAPPO O, et al. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice[J]. Mol Cancer Res, 2007, 5( 11): 1159- 1170. DOI: 10.1158/1541-7786.MCR-07-0172.
|
[21] |
de VRIES E, MAZZETTI M, TAKKENBERG B, et al. Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma[J]. Liver Int, 2020, 40( 12): 3042- 3050. DOI: 10.1111/liv.14662.
|